Assessing the Breast Cancer Risk Distribution for Women Undergoing Screening in British Columbia

Breast cancer risk estimations are both informative and useful at the population level, with many screening programs relying on these assessments to allocate resources such as breast MRI. This cross-sectional multicenter study attempts to quantify the breast cancer risk distribution for women between the ages of 40 to 79 years undergoing screening mammography in British Columbia (BC), Canada. The proportion of women at high breast cancer risk was estimated by surveying women enrolled in the Screening Mammography Program of British Columbia (SMPBC) for known breast cancer risk factors. Each respondent's 10-year risk was computed with both the Tyrer–Cuzick and Gail risk assessment models. The resulting risk distributions were evaluated using the guidelines from the National Institute for Health and Care Excellence (United Kingdom). Of the 4,266 women surveyed, 3.5% of women between the ages of 40 to 79 years were found to have a high 10-year risk of developing breast cancer using the Tyrer–Cuzick model (1.1% using the Gail model). When extrapolated to the screening population, it was estimated that 19,414 women in the SMPBC are considered to be at high breast cancer risk. These women may benefit from additional MRI screening; preliminary analysis suggests that 4 to 5 additional MRI machines would be required to screen these high-risk women. However, the use of different models and guidelines will modify the number of women qualifying for additional screening interventions, thus impacting the MRI resources required. The results of this project can now be used to inform decision-making groups about resource allocation for breast cancer screening in BC. Cancer Prev Res; 6(10); 1084–92. ©2013 AACR.

[1]  Maximilian Reiser,et al.  Prospective multicenter cohort study to refine management recommendations for women at elevated familial risk of breast cancer: the EVA trial. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[2]  E. Ward,et al.  Integrating Tools for Breast Cancer Risk Assessment, Risk Reduction, and Early Detection , 2010, Cancer Epidemiology, Biomarkers & Prevention.

[3]  M. Cowie National Institute for Health and Care Excellence. , 2015, European heart journal.

[4]  S. Pakseresht,et al.  Risk of Developing Breast Cancer by Utilizing Gail Model , 2012, Women & health.

[5]  E. Halpern,et al.  Cost‐effectiveness of alternating magnetic resonance imaging and digital mammography screening in BRCA1 and BRCA2 gene mutation carriers , 2013, Cancer.

[6]  N. Facione,et al.  Predictors of perceived breast cancer risk and the relation between perceived risk and breast cancer screening: a meta-analytic review. , 2004, Preventive medicine.

[7]  M. Gail,et al.  Projecting individualized probabilities of developing breast cancer for white females who are being examined annually. , 1989, Journal of the National Cancer Institute.

[8]  D. Berry,et al.  Determining carrier probabilities for breast cancer-susceptibility genes BRCA1 and BRCA2. , 1998, American journal of human genetics.

[9]  Jean B. Cormack,et al.  Combined screening with ultrasound and mammography vs mammography alone in women at elevated risk of breast cancer. , 2008, JAMA.

[10]  S. Cummings,et al.  Critical assessment of new risk factors for breast cancer: considerations for development of an improved risk prediction model. , 2007, Endocrine-related cancer.

[11]  K McPherson,et al.  Breast cancer—epidemiology, risk factors, and genetics , 1994, BMJ : British Medical Journal.

[12]  Mitchell H Gail,et al.  Comparing breast cancer risk assessment models. , 2010, Journal of the National Cancer Institute.

[13]  Mary Wilson,et al.  Assessing Individual Breast Cancer Risk within the U.K. National Health Service Breast Screening Program: A New Paradigm for Cancer Prevention , 2012, Cancer Prevention Research.

[14]  Andrew N Freedman,et al.  Five-Year and Lifetime Risk of Breast Cancer among U.S. Subpopulations: Implications for Magnetic Resonance Imaging Screening , 2010, Cancer Epidemiology, Biomarkers & Prevention.

[15]  Stephen W Duffy,et al.  A breast cancer prediction model incorporating familial and personal risk factors , 2004, Hereditary Cancer in Clinical Practice.

[16]  M. G. Clay Screening mammography program of British Columbia. , 1990, American journal of surgery.

[17]  S. Singletary Rating the Risk Factors for Breast Cancer , 2003, Annals of surgery.

[18]  I. Buchan,et al.  P4-11-07: Feasibility and Acceptability of Offering Breast Cancer Risk Estimation in the Context of the UK National Health Service Breast Cancer Screening Programme: A New Paradigm for Cancer Prevention. , 2011 .

[19]  P. Autier Risk Factors for Breast Cancer for Women Aged 40 to 49 Years , 2012, Annals of Internal Medicine.

[20]  D. Evans,et al.  Assessing women at high risk of breast cancer: a review of risk assessment models. , 2010, Journal of the National Cancer Institute.

[21]  A. Coldman,et al.  Comparison of nonbreast cancer incidence, survival and mortality between breast screening program participants and nonparticipants , 2008, International journal of cancer.

[22]  Anthony Howell,et al.  Breast cancer risk-assessment models , 2007, Breast Cancer Research.

[23]  Jeffrey D Blume,et al.  Reasons women at elevated risk of breast cancer refuse breast MR imaging screening: ACRIN 6666. , 2010, Radiology.

[24]  Ahmedin Jemal,et al.  Trends in Breast Cancer by Race and Ethnicity: Update 2006 , 2006, CA: a cancer journal for clinicians.

[25]  Mohd Hamid,et al.  Breast Cancer Risk Assessment Tool , 2014 .

[26]  M. Yaffe,et al.  American Cancer Society Guidelines for Breast Screening with MRI as an Adjunct to Mammography , 2007, CA: a cancer journal for clinicians.

[27]  Ben Dwamena,et al.  MRI and mammography surveillance of women at increased risk for breast cancer: recommendations using an evidence-based approach. , 2008, Academic radiology.

[28]  J. Elmore,et al.  Ten-year risk of false positive screening mammograms and clinical breast examinations. , 1998, The New England journal of medicine.

[29]  Etta D Pisano,et al.  Detection of breast cancer with addition of annual screening ultrasound or a single screening MRI to mammography in women with elevated breast cancer risk. , 2012, JAMA.

[30]  S. Jackson,et al.  Breast cancer risk assessment in 64,659 women at a single high-volume mammography clinic. , 2012, Academic radiology.

[31]  N Risch,et al.  Genetic analysis of breast cancer in the cancer and steroid hormone study. , 1991, American journal of human genetics.

[32]  Konstantin Strauch,et al.  Breast cancer risk assessment across the risk continuum: genetic and nongenetic risk factors contributing to differential model performance , 2012, Breast Cancer Research.

[33]  Sara Godward,et al.  Impact of false-positive mammography on subsequent screening attendance and risk of cancer , 2002, Breast Cancer Research.

[34]  D. Easton,et al.  The BOADICEA model of genetic susceptibility to breast and ovarian cancer , 2004, British Journal of Cancer.

[35]  D. Easton,et al.  Risks of cancer in BRCA1-mutation carriers , 1994, The Lancet.

[36]  D. Plewes,et al.  Systematic Review: Using Magnetic Resonance Imaging to Screen Women at High Risk for Breast Cancer , 2008, Annals of Internal Medicine.